222 related articles for article (PubMed ID: 8566137)
1. Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist.
Mizuno M; Sada T; Ikeda M; Fukuda N; Miyamoto M; Yanagisawa H; Koike H
Eur J Pharmacol; 1995 Oct; 285(2):181-8. PubMed ID: 8566137
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
[TBL] [Abstract][Full Text] [Related]
3. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.
Lee SH; Jung YS; Lee BH; Yun SI; Yoo SE; Shin HS
J Cardiovasc Pharmacol; 1999 Mar; 33(3):367-74. PubMed ID: 10069670
[TBL] [Abstract][Full Text] [Related]
4. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist.
Shibasaki M; Fujimori A; Takanashi M; Kusayama T; Tokioka T; Satoh Y; Okazaki T; Uchida W; Inagaki O; Yanagisawa I
Eur J Pharmacol; 1997 Sep; 335(2-3):167-73. PubMed ID: 9369370
[TBL] [Abstract][Full Text] [Related]
6. The in vitro pharmacological profile of KR31080, a nonpeptide AT1 receptor antagonist.
Hong KW; Kim CD; Lee SH; Yoo SE
Fundam Clin Pharmacol; 1998; 12(1):64-9. PubMed ID: 9523186
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological properties of KT3-671, a novel nonpeptide angiotensin II receptor antagonist.
Mochizuki S; Sato T; Furuta K; Hase K; Ohkura Y; Fukai C; Kosakai K; Wakabayashi S; Tomiyama A
J Cardiovasc Pharmacol; 1995 Jan; 25(1):22-9. PubMed ID: 7723348
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profiles of a novel non-peptide angiotensin II type I receptor antagonist HR720 in vitro and in vivo.
Jin D; Song K; Oka Y; Takai S; Shiota N; Miyazaki M
Jpn J Pharmacol; 1997 Nov; 75(3):259-66. PubMed ID: 9434257
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist.
Wong PC; Hart SD; Chiu AT; Herblin WF; Carini DJ; Smith RD; Wexler RR; Timmermans PB
J Pharmacol Exp Ther; 1991 Nov; 259(2):861-70. PubMed ID: 1941632
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
[TBL] [Abstract][Full Text] [Related]
12. The pharmacologic profile of 606A, a novel angiotensin II receptor antagonist.
Hashimoto Y; Harada Y; Narita H; Naito K; Murata S
J Cardiovasc Pharmacol; 1997 Feb; 29(2):284-90. PubMed ID: 9057080
[TBL] [Abstract][Full Text] [Related]
13. In vitro pharmacology of a novel non-peptide angiotensin II-receptor antagonist, E4177.
Okunishi H; Song K; Oka Y; Kobayashi T; Kawamoto T; Ishihara H; Mori N; Miyazaki M
Jpn J Pharmacol; 1993 Jul; 62(3):239-44. PubMed ID: 8411773
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of TH-142177, a novel orally active AT1-receptor antagonist.
Nozawa Y; Haruno A; Oda N; Yamasaki Y; Matsuura N; Miyake H; Yamada S; Kimura R
Fundam Clin Pharmacol; 1997; 11(5):395-401. PubMed ID: 9342592
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of KR-30988, a novel non-peptide AT1 receptor antagonist, in rat, rabbit and dog.
Lee BH; Lee SH; Jung YS; Seo HW; Yoo SE; Shin HS
J Pharm Pharmacol; 1999 Oct; 51(10):1191-200. PubMed ID: 10579691
[TBL] [Abstract][Full Text] [Related]
16. In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
Cazes M; Provost D; Versigny A; Cloarec A
Eur J Pharmacol; 1995 Sep; 284(1-2):157-70. PubMed ID: 8549620
[TBL] [Abstract][Full Text] [Related]
17. Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazoles.
Kubo K; Inada Y; Kohara Y; Sugiura Y; Ojima M; Itoh K; Furukawa Y; Nishikawa K; Naka T
J Med Chem; 1993 Jun; 36(12):1772-84. PubMed ID: 8510105
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist.
Cazaubon C; Gougat J; Bousquet F; Guiraudou P; Gayraud R; Lacour C; Roccon A; Galindo G; Barthelemy G; Gautret B
J Pharmacol Exp Ther; 1993 May; 265(2):826-34. PubMed ID: 8496828
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic profiles of KRH-594, a novel nonpeptide angiotensin II-receptor antagonist.
Tamura K; Okuhira M; Amano H; Inokuma K; Hirata T; Mikoshiba I; Hashimoto K
J Cardiovasc Pharmacol; 1997 Nov; 30(5):607-15. PubMed ID: 9388043
[TBL] [Abstract][Full Text] [Related]
20. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Oct; 255(1):211-7. PubMed ID: 2213556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
